Yi Chang
Director/Board Member at NONGFU SPRING CO., LTD.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Hui Shao | M | 55 |
YishengBio Co., Ltd.
 YishengBio Co., Ltd. BiotechnologyHealth Technology Yishengbio Co., Ltd. is an investment holding company that engages in the research and development, manufacture, and sale of vaccines and therapeutic biologics for infectious diseases and cancer. It focuses on the PIKA immunomodulation technology platform and production, sale of YSJA rabies vaccine. Its geographical segment include Mainland China, and other countries. The company was founded by Yi Zhang on November 16, 2020 and is headquartered in China. | 14 years |
| Xu Guang Ma | M | 53 | 10 years | |
| Ye Chen | F | 46 | 18 years | |
| Ji Li | M | 46 | 9 years | |
| Shan Shan Zhong | M | 70 | 28 years | |
| Qiong Zhi Wang | F | 67 | 24 years | |
| Hai Jian He | M | 42 | 3 years | |
| Kuan Kai Tseng | M | 47 | 18 years | |
| Ji Liu Du | F | 54 |
Shanghai Advanced Institute of Finance
China Institute of Internal Audit
| 22 years |
| Yuan Lu | M | 69 | 5 years | |
| Lin You Han | F | 43 | 4 years | |
| Lei Yang | M | 57 | 5 years | |
| Viren Mehta | M | 74 |
YishengBio Co., Ltd.
YishengBio Co., Ltd. BiotechnologyHealth Technology Yishengbio Co., Ltd. is an investment holding company that engages in the research and development, manufacture, and sale of vaccines and therapeutic biologics for infectious diseases and cancer. It focuses on the PIKA immunomodulation technology platform and production, sale of YSJA rabies vaccine. Its geographical segment include Mainland China, and other countries. The company was founded by Yi Zhang on November 16, 2020 and is headquartered in China. | 3 years |
| Fan Xin | M | 45 | 1 years | |
| Sheng Xi | M | 61 |
China Institute of Internal Audit
| - |
| Chun Yuan Wu | F | 46 |
Ernst & Young (China)
YishengBio Co., Ltd.
YishengBio Co., Ltd. BiotechnologyHealth Technology Yishengbio Co., Ltd. is an investment holding company that engages in the research and development, manufacture, and sale of vaccines and therapeutic biologics for infectious diseases and cancer. It focuses on the PIKA immunomodulation technology platform and production, sale of YSJA rabies vaccine. Its geographical segment include Mainland China, and other countries. The company was founded by Yi Zhang on November 16, 2020 and is headquartered in China. | 17 years |
| Shao Jing Tong | M | 53 |
YishengBio Co., Ltd.
YishengBio Co., Ltd. BiotechnologyHealth Technology Yishengbio Co., Ltd. is an investment holding company that engages in the research and development, manufacture, and sale of vaccines and therapeutic biologics for infectious diseases and cancer. It focuses on the PIKA immunomodulation technology platform and production, sale of YSJA rabies vaccine. Its geographical segment include Mainland China, and other countries. The company was founded by Yi Zhang on November 16, 2020 and is headquartered in China. | - |
| Han Zhong Li | M | 56 |
YishengBio Co., Ltd.
YishengBio Co., Ltd. BiotechnologyHealth Technology Yishengbio Co., Ltd. is an investment holding company that engages in the research and development, manufacture, and sale of vaccines and therapeutic biologics for infectious diseases and cancer. It focuses on the PIKA immunomodulation technology platform and production, sale of YSJA rabies vaccine. Its geographical segment include Mainland China, and other countries. The company was founded by Yi Zhang on November 16, 2020 and is headquartered in China. | - |
| Xi Yue Liu | M | 51 | 7 years | |
| Bei Huang | F | 46 | 3 years | |
| Na Ren | F | 46 | 4 years | |
| Dao Cheng Wang | M | 83 |
China Institute of Internal Audit
| 19 years |
| Guo Ming Bao | F | 72 |
China Institute of Internal Audit
| - |
| Yong Yao Lei | M | 77 | 5 years | |
| Lu Lu Zhou | F | 67 | 5 years | |
| Xian Song Xiang | M | 42 | 2 years | |
| Duane Lee | M | 68 | 24 years | |
| Ajit Shetty | M | 77 |
YishengBio Co., Ltd.
YishengBio Co., Ltd. BiotechnologyHealth Technology Yishengbio Co., Ltd. is an investment holding company that engages in the research and development, manufacture, and sale of vaccines and therapeutic biologics for infectious diseases and cancer. It focuses on the PIKA immunomodulation technology platform and production, sale of YSJA rabies vaccine. Its geographical segment include Mainland China, and other countries. The company was founded by Yi Zhang on November 16, 2020 and is headquartered in China. | 3 years |
| Xiao Jun Yang | F | 38 | 13 years | |
| Li Min Wu | F | 51 | 1 years | |
| Lei Wen Yao | M | 42 | 5 years | |
| Min Liu | F | 47 | 1 years | |
| Ming Hong Rao | M | 49 | 25 years | |
| Sheng Tang | M | 46 |
Shanghai Advanced Institute of Finance
| 15 years |
| Yuehe Lu | F | 39 |
China Institute of Internal Audit
| - |
| Lian Xue | F | 51 | 1 years | |
| Zhong Kai Shi | M | 59 |
YishengBio Co., Ltd.
YishengBio Co., Ltd. BiotechnologyHealth Technology Yishengbio Co., Ltd. is an investment holding company that engages in the research and development, manufacture, and sale of vaccines and therapeutic biologics for infectious diseases and cancer. It focuses on the PIKA immunomodulation technology platform and production, sale of YSJA rabies vaccine. Its geographical segment include Mainland China, and other countries. The company was founded by Yi Zhang on November 16, 2020 and is headquartered in China. | 4 years |
| Yuan Liu | M | 37 |
YishengBio Co., Ltd.
YishengBio Co., Ltd. BiotechnologyHealth Technology Yishengbio Co., Ltd. is an investment holding company that engages in the research and development, manufacture, and sale of vaccines and therapeutic biologics for infectious diseases and cancer. It focuses on the PIKA immunomodulation technology platform and production, sale of YSJA rabies vaccine. Its geographical segment include Mainland China, and other countries. The company was founded by Yi Zhang on November 16, 2020 and is headquartered in China. | 5 years |
| Li Wei | M | 53 |
Shanghai Advanced Institute of Finance
| 3 years |
| Hong Gang Teng | M | 51 |
YishengBio Co., Ltd.
YishengBio Co., Ltd. BiotechnologyHealth Technology Yishengbio Co., Ltd. is an investment holding company that engages in the research and development, manufacture, and sale of vaccines and therapeutic biologics for infectious diseases and cancer. It focuses on the PIKA immunomodulation technology platform and production, sale of YSJA rabies vaccine. Its geographical segment include Mainland China, and other countries. The company was founded by Yi Zhang on November 16, 2020 and is headquartered in China. | 7 years |
| Yu Ying Yang | F | 52 | 2 years | |
| Gang Li | M | 42 |
YishengBio Co., Ltd.
YishengBio Co., Ltd. BiotechnologyHealth Technology Yishengbio Co., Ltd. is an investment holding company that engages in the research and development, manufacture, and sale of vaccines and therapeutic biologics for infectious diseases and cancer. It focuses on the PIKA immunomodulation technology platform and production, sale of YSJA rabies vaccine. Its geographical segment include Mainland China, and other countries. The company was founded by Yi Zhang on November 16, 2020 and is headquartered in China. | 5 years |
| Qun Xiang Shen | F | 44 | 13 years | |
| Yan Chen | F | 43 | 17 years | |
| Jing Jun Li | M | - |
China Institute of Internal Audit
| 13 years |
| Kai Long Niu | M | 50 |
Shanghai Advanced Institute of Finance
| - |
| Qi Ang Li | M | 42 | 5 years | |
| Shu Zi Zhong | M | 36 | 7 years | |
| Wan Qing Wang | M | 60 |
China Institute of Internal Audit
| - |
| Lin Zhou | M | 64 |
Shanghai Advanced Institute of Finance
| 6 years |
| Gui Di Luo | F | 48 |
China Institute of Internal Audit
| - |
| Chuan Bing Cai | M | 84 |
China Institute of Internal Audit
| - |
| Chuan Mo Han | M | 74 |
China Institute of Internal Audit
| - |
| Jin Song Tan | M | 59 |
China Institute of Internal Audit
| - |
| Zhi Hua Xia | F | 70 |
China Institute of Internal Audit
| - |
| Bi Hong Peng | M | 60 |
China Institute of Internal Audit
| - |
| Rong Sheng Qin | M | 62 |
China Institute of Internal Audit
| - |
| Lei Fu | M | 73 |
China Institute of Internal Audit
| - |
| Wei Jie Yin | M | 61 |
China Institute of Internal Audit
| - |
| Shi En Mai | M | 48 |
China Institute of Internal Audit
| 20 years |
| Tian Xiong Wang | M | 52 |
China Institute of Internal Audit
| - |
| Ren Ping Yi | F | 81 |
China Institute of Internal Audit
| - |
| Guo Hua Chi | M | 50 |
China Institute of Internal Audit
| 6 years |
| Xue Feng Li | M | 51 |
China Institute of Internal Audit
| - |
| Guang Shi An | M | 62 |
China Institute of Internal Audit
| - |
| Teng Zhou | M | 37 | 5 years | |
| Sheng Sen Huang | M | 52 |
Grant Thornton LLP (China)
| - |
| Xue Li | M | 60 |
China Institute of Internal Audit
| - |
| Rong Xing Xie | M | 74 |
Shanghai Advanced Institute of Finance
| - |
| Zhen Huan Liu | M | 69 |
China Institute of Internal Audit
| 11 years |
| Fei Wu | M | 52 |
Shanghai Advanced Institute of Finance
| 11 years |
| Yu Zhang | M | 41 |
Shanghai Advanced Institute of Finance
| - |
| Ye Zhou | M | 58 |
Shanghai Advanced Institute of Finance
| - |
| Cai Yong Wang | M | 73 |
China Institute of Internal Audit
| - |
| X Li David | M | 60 |
Shanghai Advanced Institute of Finance
| 6 years |
| Feng Li | M | 48 |
Shanghai Advanced Institute of Finance
| 9 years |
| Wing Yat Lui | M | 35 |
YishengBio Co., Ltd.
YishengBio Co., Ltd. BiotechnologyHealth Technology Yishengbio Co., Ltd. is an investment holding company that engages in the research and development, manufacture, and sale of vaccines and therapeutic biologics for infectious diseases and cancer. It focuses on the PIKA immunomodulation technology platform and production, sale of YSJA rabies vaccine. Its geographical segment include Mainland China, and other countries. The company was founded by Yi Zhang on November 16, 2020 and is headquartered in China. | - |
| Xiang Lin Li | M | 61 |
Shanghai Advanced Institute of Finance
| - |
| Ching Yi Li | F | - | 1 years | |
| Si Rui Li | M | 42 |
China Institute of Internal Audit
| 13 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Angela Harper | F | 55 |
Texas Tech University
| 5 years |
| Steven Purvis | M | 59 |
University of Missouri
| 8 years |
| Jyuo-Min Shyu | M | 70 |
National Taiwan University
| 6 years |
| Stacie Moore | F | - |
Texas Tech University
| 6 years |
| Andrea Wood | F | - |
Texas Tech University
| 5 years |
| Ming Hsiung Liu | M | 67 |
National Taiwan University
| 4 years |
| Janto Salim | M | 56 |
Texas Tech University
| 6 years |
| Craig Ault | M | - |
University of Missouri
| 5 years |
| David C. Gobberdiel | M | - |
University of Missouri
| 6 years |
| Randy D. Roe | M | - |
Texas Tech University
| 6 years |
| Scott Summerford | M | - |
Texas Tech University
| 5 years |
| Stephen R. Darling | M | - |
Texas Tech University
| 3 years |
| Yi Shuen Wu | M | 65 |
National Taiwan University
| 4 years |
| Dale Cox | M | - |
Texas Tech University
| 6 years |
| Philip Strawbridge | M | 69 |
University of Missouri
| 7 years |
| E. Clifton Hoover | M | - |
Texas Tech University
| 5 years |
| Elizabeth Happe | F | - |
University of Missouri
| 7 years |
| Tzu Ming Wang | M | - |
National Taiwan University
| 4 years |
| Lucas Chang | M | 69 |
National Taiwan University
| 4 years |
| Shin Chun Hsu | M | 68 |
National Taiwan University
| 4 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| China | 80 | 80.00% |
| United States | 14 | 14.00% |
| Taiwan | 6 | 6.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Yi Chang
- Personal Network
